Global Prospective Safety Analysis of Rivaroxaban.
暂无分享，去创建一个
P. Kirchhof | A. Camm | P. Amarenco | F. Lanas | Young-Hoon Kim | A. Turpie | S. Haas | M. Bach | G. Radaideh | Marc Lambelet | S. Hess | Young-Hoon Kim | Global Xantus program Investigators